Brookfield Asset Management Ltd. has revived talks with Grifols SA’s main shareholder about a potential offer for the Spanish blood-plasma company following a failed attempt last year, according to people familiar with the matter. Brookfield has been holding discussions with the Grifols family, which holds about 35% of the firm, said the people, who asked not to be named. Talks are ongoing and it’s unclear if Brookfield will go ahead with a formal offer. Shares of Grifols, a maker of medicines from blood plasma to treat illnesses such as hepatitis, rose as much as 13% in Madrid on Wednesday.
Read the full article: Brookfield Said to Revive Talks on Potential Grifols Offer //
Source: https://www.bnnbloomberg.ca/business/company-news/2025/04/02/brookfield-said-to-revive-talks-on-potential-grifols-offer/